We showed that metformin, notably at a high concentration, when combined with Venetoclax, increased sensitivity of KPUM-UH1, a double hit cell line that is typically chemotherapy resistant, and SUDHL-4, a germinal center origin DLBCL cell line, to the bcl-2 inhibitor. The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.